Beigene Ltd (NASDAQ:BGNE)

135.52
Delayed Data
As of Sep 20
 +2.57 / +1.93%
Today’s Change
105.19
Today|||52-Week Range
179.57
-3.38%
Year-to-Date
No recent news for Beigene Ltd.

Today’s Trading

Previous close132.95
Today’s open132.46
Day’s range132.03 - 137.86
Volume423,599
Average volume (3 months)293,737
Market cap$8.2B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-670.85%
Earnings growth (this year)+6.16%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-17.21%
P/E ratioNM
Price/Sales39.27
Price/Book4.67

Competitors

 Today’s
change
Today’s
% change
TEVATeva Pharmaceutical-0.08-1.06%
BBIOBridgeBio Pharma Inc+1.74+7.09%
AKRXAkorn Inc+0.43+11.72%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$3.76
Annual revenue (last year)$198.0M
Annual profit (last year)-$673.2M
Net profit margin-339.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John V. Oyler
President &
General Manager-China Region
Xiao Bin Wu
Corporate headquarters
Beijing, Beijing

Forecasts